Cargando…

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis

Ewing sarcoma (EWS) is the second most common bone and soft tissue-associated malignancy in children and young adults. It is driven by the fusion oncogene EWS/FLI1 and characterized by rapid growth and early metastasis. We have previously discovered that the mRNA binding protein IGF2BP3 constitutes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mancarella, Caterina, Caldoni, Giulia, Ribolsi, Irene, Parra, Alessandro, Manara, Maria Cristina, Mercurio, Arthur M., Morrione, Andrea, Scotlandi, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347992/ https://www.ncbi.nlm.nih.gov/pubmed/32719743 http://dx.doi.org/10.3389/fonc.2020.00994

Ejemplares similares

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021)

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
por: Mancarella, Caterina, et al.
Publicado: (2023)

CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling
por: Manara, Maria Cristina, et al.
Publicado: (2016)

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
por: Mancarella, Caterina, et al.
Publicado: (2023)

Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021)

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
por: Pinca, Rosa Simona, et al.
Publicado: (2017)

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma
por: Martinelli, Marcella, et al.
Publicado: (2022)

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers
por: Mancarella, Caterina, et al.
Publicado: (2022)

Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
por: Garofalo, Cecilia, et al.
Publicado: (2013)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018)

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients
por: Savola, Suvi, et al.
Publicado: (2011)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
por: Chiarini, Francesca, et al.
Publicado: (2022)

Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications
por: Amaral, Ana Teresa, et al.
Publicado: (2014)

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
por: Mancarella, Caterina, et al.
Publicado: (2020)

CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression
por: Martinelli, Marcella, et al.
Publicado: (2016)

miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness
por: De Feo, Alessandra, et al.
Publicado: (2022)

The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease
por: Berghuis, Dagmar, et al.
Publicado: (2012)

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma
por: Sand, Laurens G. L., et al.
Publicado: (2017)

An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma
por: Mosakhani, Neda, et al.
Publicado: (2012)

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
por: Carrabotta, Marianna, et al.
Publicado: (2022)

CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
por: Huang, Ai-Fang, et al.
Publicado: (2013)

Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors
por: Savola, Suvi, et al.
Publicado: (2009)

A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcoma
por: Krook, Melanie A., et al.
Publicado: (2016)

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
por: Cristalli, Camilla, et al.
Publicado: (2022)

Aggressive high-grade Ewing's sarcoma of maxilla: A rare case report
por: Yogesh, TL, et al.
Publicado: (2018)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
por: De Feo, Alessandra, et al.
Publicado: (2019)

Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression
por: Jin, Zhe, et al.
Publicado: (2012)

Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
por: Dallmayer, Marlene, et al.
Publicado: (2019)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)

The First European Interdisciplinary Ewing Sarcoma Research Summit
por: Kovar, Heinrich, et al.
Publicado: (2012)

Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines
por: Garofalo, Cecilia, et al.
Publicado: (2015)

Ewing's sarcoma of zygoma
por: Deshingkar, SA, et al.
Publicado: (2009)

Ewing's sarcoma of the mandible
por: Rao, B. H. Sripathi, et al.
Publicado: (2011)

Chemotherapy in Ewing’s sarcoma
por: Jain, Sandeep, et al.
Publicado: (2010)

The Biology of Ewing Sarcoma
por: Ross, Keir A., et al.
Publicado: (2013)

Ewing's Sarcoma of the Finger
por: Gökalp, Mehmet Ata, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jh44ifu21ndtvc3mi1ame9gihr